Press Releases & Statements

Investor Relations

Month Year

Month Year

Novavax to Make Multiple Presentations at RSV Vaccines for the World
- RSV
Nov 16, 2015
Novavax to Present at the Stifel 2015 Healthcare Conference
- Corporate and Finance
Nov 10, 2015
Novavax Initiates Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults
- RSV
Nov 9, 2015
Novavax Reports Third Quarter 2015 Financial Results
- Corporate and Finance
Nov 9, 2015
Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 9, 2015
- Corporate and Finance
Nov 2, 2015
Novavax Initiates Phase 2 Safety and Immunogenicity Trial to Evaluate Annual Re-Dosing of the RSV F Vaccine in Older Adults
- RSV
Oct 22, 2015
Novavax Announces Management Promotion
- Corporate and Finance
Oct 1, 2015
Novavax Announces Grant of Up to $89 Million to Support Development of RSV F Vaccine to Protect Infants Via Maternal Immunization
- RSV
Sep 29, 2015
Novavax Announces Positive Top-Line Data from Phase 2 Clinical Trial of RSV F Vaccine to Protect Infants via Maternal Immunization
- RSV
Sep 29, 2015
Novavax to Host 3rd Annual Analyst and Investor Meeting
- Corporate and Finance
Sep 29, 2015

Show per page